FR2601875B1 - WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND SORBITOL - Google Patents

WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND SORBITOL

Info

Publication number
FR2601875B1
FR2601875B1 FR878710367A FR8710367A FR2601875B1 FR 2601875 B1 FR2601875 B1 FR 2601875B1 FR 878710367 A FR878710367 A FR 878710367A FR 8710367 A FR8710367 A FR 8710367A FR 2601875 B1 FR2601875 B1 FR 2601875B1
Authority
FR
France
Prior art keywords
cysteine
sorbitol
acetyl
water
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR878710367A
Other languages
French (fr)
Other versions
FR2601875A1 (en
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharzam International SA
Original Assignee
Inpharzam International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam International SA filed Critical Inpharzam International SA
Publication of FR2601875A1 publication Critical patent/FR2601875A1/en
Application granted granted Critical
Publication of FR2601875B1 publication Critical patent/FR2601875B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR878710367A 1986-07-24 1987-07-22 WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND SORBITOL Expired - Lifetime FR2601875B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2974/86A CH666814A5 (en) 1986-07-24 1986-07-24 WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN.

Publications (2)

Publication Number Publication Date
FR2601875A1 FR2601875A1 (en) 1988-01-29
FR2601875B1 true FR2601875B1 (en) 1992-02-21

Family

ID=4245819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878710367A Expired - Lifetime FR2601875B1 (en) 1986-07-24 1987-07-22 WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND SORBITOL

Country Status (8)

Country Link
BE (1) BE1000168A3 (en)
CH (1) CH666814A5 (en)
DE (1) DE3723734A1 (en)
FR (1) FR2601875B1 (en)
GB (1) GB2192789B (en)
IT (1) IT1222103B (en)
NL (1) NL194154C (en)
SE (1) SE500493C2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (en) * 1988-04-29 1990-03-22 Altergon Sa SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCISTEIN
CH674940A5 (en) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
DE3909049A1 (en) * 1989-03-18 1990-09-20 Arthur Boskamp PREPARATION AND THEIR USE
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (en) * 1992-12-02 1995-12-12 Zambon Spa SYRUP CONTAINING N-ACETYL-CISTEIN
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
DE4406261C2 (en) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Use of thiol compounds to reduce body fat
DE4329857C2 (en) * 1993-09-03 1995-08-24 Deutsches Krebsforsch Connection to strengthen the immune system and immune reactions
BE1007926A3 (en) * 1994-01-31 1995-11-21 Zambon Int Pharma Pharmaceutical composition containing n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
WO2000018392A1 (en) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
CN1320160A (en) 1998-09-25 2001-10-31 格利科克斯有限公司 Fructosamine oxidase assay method and materials
EP1293251A1 (en) * 2001-09-14 2003-03-19 Holland Sweetener Company V.o.F. Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder
ES2386782T3 (en) 2002-03-08 2012-08-30 Philera New Zealand Limited Prevention and / or treatment of cardiovascular disease and / or associated heart failure
MXPA05002883A (en) 2002-08-20 2005-10-05 Protemix Corp Ltd Dosage forms and related therapies.
EP1778618B1 (en) 2004-07-19 2013-12-25 PhilERA New Zealand Limited Synthesis of triethylenetetramines
GR1007236B (en) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, New pharmaceutical composition of n-acetylcysteine granules and production method thereof
IT1399492B1 (en) * 2010-04-13 2013-04-19 Alpex Pharma Sa EFFERVESCENT PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCISTEIN.
CN103142505B (en) * 2013-03-29 2015-03-11 山东罗欣药业集团股份有限公司 Acetylcysteine composition granules and preparation method thereof
ES2877679T3 (en) 2017-12-31 2021-11-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Pharmaceutical composition comprising acetylcytysteine without methylparaben or propylparaben
CN113559078A (en) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 Preparation method of acetylcysteine effervescent tablets

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617638A1 (en) * 1967-05-24 1971-05-13 Miles Lab Tablet binder
CH646843A5 (en) * 1982-02-17 1984-12-28 Xyrofin Ag Sugar substitute, method for its production, and its use
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317558A1 (en) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Oral antisnoring composition
DE3317530A1 (en) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antisnoring composition
IT1170268B (en) * 1983-12-21 1987-06-03 Zambon Spa USE OF ACETYLCISTEIN TO REDUCE THE INCREASE IN THE PROLIEFERATION OF THE BASAL CELLS OF THE RESPIRATORY THRACHEO-BRONCHIAL EPITHELIUM INDUCED BY TOBACCO SMOKE IN MAMMALS
DE3514995A1 (en) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Use of sulfhydryl pharmaceuticals for combating damage to the gastric mucosa

Also Published As

Publication number Publication date
GB2192789B (en) 1990-01-31
SE8702941L (en) 1988-01-25
DE3723734A1 (en) 1988-02-04
CH666814A5 (en) 1988-08-31
BE1000168A3 (en) 1988-07-05
IT8721410A0 (en) 1987-07-23
NL8701744A (en) 1988-02-16
NL194154B (en) 2001-04-02
SE8702941D0 (en) 1987-07-23
GB2192789A (en) 1988-01-27
IT1222103B (en) 1990-08-31
FR2601875A1 (en) 1988-01-29
NL194154C (en) 2001-08-03
DE3723734C2 (en) 1992-05-21
GB8717581D0 (en) 1987-09-03
SE500493C2 (en) 1994-07-04

Similar Documents

Publication Publication Date Title
FR2601875B1 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND SORBITOL
FR2601876B1 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND CITRIC ACID
FR2582513B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
FR2586562B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A-METHYLHISTAMINE
FR2604357B1 (en) PHARMACEUTICAL AND ANTI-ACNE COSMETIC COMPOSITION
FR2602974B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICOTINE OR DERIVATIVES THEREOF
MC1782A1 (en) PHARMACEUTICAL PREPARATION
IT1219941B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CEFUROXIMA AXETIL AND PROCEDURE TO PREPARE THEM
FR2596758B1 (en) IMPROVED PHARMACEUTICAL SALTS OF AMLODIPINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2430410B1 (en) PHENETHANOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2626002B1 (en) DIDEOXYDIDEHYDROCARBOCYCLIC NUCLEOSIDES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
LU80795A1 (en) NEW THIENOHYDANTOINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2645152B1 (en) 3H-PTERIDINONES-4, METHODS OF PREPARATION AND MEDICAMENTS CONTAINING THEM
FR2596651B1 (en) NOVEL LIPOSOMES BASED ON PHOSPHATIDYLINOSITOLMANNOSIDES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE888797A (en) CARNITINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2608921B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING RANITIDINE
FR2446819B1 (en) 6-ALKYL DERIVATIVES OF 1,2-DIHYDRO-2-OXONICOTINIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2598617B1 (en) PHARMACEUTICAL COMPOSITION
FR2618333B1 (en) PHARMACEUTICAL AND / OR COSMETIC COMPOSITION FOR TOPICAL USE CONTAINING RHAMSAM GUM
PT84933B (en) PROCESS FOR THE PREPARATION OF CYCLODEPSIPEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT82364B (en) PROCESS FOR THE PREPARATION OF NITROFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2609392B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRANOQUINOLEINS
FR2634764B1 (en) OXAZA HETEROCYCLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2512822B1 (en) DERIVATIVES OF THE ANTIBIOTIC TYLOSINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT82853A (en) PROCESS FOR THE PREPARATION OF NEW BENZAMIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name